These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
64. Morphine can produce analgesia via spinal kappa opioid receptors in the absence of mu opioid receptors. Yamada H; Shimoyama N; Sora I; Uhl GR; Fukuda Y; Moriya H; Shimoyama M Brain Res; 2006 Apr; 1083(1):61-9. PubMed ID: 16530171 [TBL] [Abstract][Full Text] [Related]
65. Intracerebroventricular morphine produces antinociception by evoking gamma-aminobutyric acid release through activation of 5-hydroxytryptamine 3 receptors in the spinal cord. Kawamata T; Omote K; Toriyabe M; Kawamata M; Namiki A Anesthesiology; 2002 May; 96(5):1175-82. PubMed ID: 11981159 [TBL] [Abstract][Full Text] [Related]
66. C-terminal hydrazide modification changes the spinal antinociceptive profiles of endomorphins in mice. Wang CL; Yang DJ; Yuan BY; Wang Y Peptides; 2018 Jan; 99():128-133. PubMed ID: 28888771 [TBL] [Abstract][Full Text] [Related]
71. [Dmt(1)]DALDA is highly selective and potent at mu opioid receptors, but is not cross-tolerant with systemic morphine. Riba P; Ben Y; Nguyen TM; Furst S; Schiller PW; Lee NM Curr Med Chem; 2002 Jan; 9(1):31-9. PubMed ID: 11860345 [TBL] [Abstract][Full Text] [Related]
72. Potency differences for D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 as an antagonist of peptide and alkaloid micro-agonists in an antinociception assay. Sterious SN; Walker EA J Pharmacol Exp Ther; 2003 Jan; 304(1):301-9. PubMed ID: 12490605 [TBL] [Abstract][Full Text] [Related]
73. Synergistic analgesic effects between neuronostatin and morphine at the supraspinal level. Yang SB; Yang AM; Shao TJ; Su SF; Chen Q Peptides; 2013 Jun; 44():105-10. PubMed ID: 23548325 [TBL] [Abstract][Full Text] [Related]
74. Effects of kappa-agonist on the antinociception and locomotor enhancing action induced by morphine in mice. Narita M; Takahashi Y; Takamori K; Funada M; Suzuki T; Misawa M; Nagase H Jpn J Pharmacol; 1993 May; 62(1):15-24. PubMed ID: 8393497 [TBL] [Abstract][Full Text] [Related]
75. Possible involvement of dynorphin A release via mu1-opioid receptor on supraspinal antinociception of endomorphin-2. Sakurada S; Sawai T; Mizoguchi H; Watanabe H; Watanabe C; Yonezawa A; Morimoto M; Sato T; Komatsu T; Sakurada T Peptides; 2008 Sep; 29(9):1554-60. PubMed ID: 18571771 [TBL] [Abstract][Full Text] [Related]
76. Opioid delta-receptor involvement in supraspinal and spinal antinociception in mice. Heyman JS; Mulvaney SA; Mosberg HI; Porreca F Brain Res; 1987 Sep; 420(1):100-8. PubMed ID: 2823970 [TBL] [Abstract][Full Text] [Related]
77. Involvement of spinal kappa opioid receptors in the antinociception produced by intrathecally administered corticotropin-releasing factor in mice. Song ZH; Takemori AE J Pharmacol Exp Ther; 1990 Aug; 254(2):363-8. PubMed ID: 2166788 [TBL] [Abstract][Full Text] [Related]
78. Evidence that endogenous opioids mediate the antinociceptive effects of intrathecally administered calcium in mice. Smith FL; Dewey WL J Pharmacol Exp Ther; 1992 Sep; 262(3):995-1003. PubMed ID: 1326632 [TBL] [Abstract][Full Text] [Related]
79. Electrical stimulation at traditional acupuncture sites in periphery produces brain opioid-receptor-mediated antinociception in rats. Chen XH; Geller EB; Adler MW J Pharmacol Exp Ther; 1996 May; 277(2):654-60. PubMed ID: 8627542 [TBL] [Abstract][Full Text] [Related]
80. Enhancement of morphine antinociception by a CCKB antagonist in mice is mediated via opioid delta receptors. Vanderah TW; Bernstein RN; Yamamura HI; Hruby VJ; Porreca F J Pharmacol Exp Ther; 1996 Jul; 278(1):212-9. PubMed ID: 8764354 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]